Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12890841 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab
2 Unknown  Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
Condition: Lymphedema
Intervention: Drug: Bevacizumab

Indicates status has not been verified in more than two years